000538 雲南白藥
按盤價 
55.570 +0.710 (+1.294%)
55.570 +0.710 (+1.294%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 13.067 | 12.068 | 10.446 | 7.822 | 7.354 |
| 總資產報酬率 ROA (%) | 9.616 | 8.902 | 7.644 | 5.681 | 5.216 |
| 投入資產回報率 ROIC (%) | 11.622 | 10.524 | 8.874 | 6.543 | 6.141 | 邊際利潤分析 |
| 銷售毛利率 (%) | 29.509 | 27.898 | 26.506 | 26.323 | 27.150 |
| 營業利潤率 (%) | 14.662 | 14.267 | 12.351 | 9.239 | 9.582 |
| 息稅前利潤/營業總收入 (%) | 14.559 | 13.811 | 11.656 | 8.315 | 8.862 |
| 淨利潤/營業總收入 (%) | 12.601 | 11.908 | 10.541 | 7.784 | 7.691 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 82.352 | 84.903 | 83.614 | 130.329 | 133.101 |
| 價值變動淨收益/利潤總額(%) | 19.087 | 16.074 | 18.733 | 7.353 | -25.414 |
| 營業外收支淨額/利潤總額(%) | 0.072 | -0.473 | -0.259 | 0.169 | -0.101 | 償債能力分析 |
| 流動比率 (X) | 2.640 | 2.656 | 2.851 | 2.631 | 3.578 |
| 速動比率 (X) | 2.157 | 2.166 | 2.345 | 2.042 | 2.919 |
| 資產負債率 (%) | 26.021 | 26.549 | 25.805 | 27.745 | 26.560 |
| 帶息債務/全部投入資本 (%) | 7.680 | 9.186 | 11.205 | 13.757 | 13.885 |
| 股東權益/帶息債務 (%) | 1,168.637 | 959.228 | 770.454 | 607.468 | 602.950 |
| 股東權益/負債合計 (%) | 283.576 | 276.421 | 287.336 | 260.266 | 275.012 |
| 利息保障倍數 (X) | -127.881 | -35.545 | -17.585 | -8.849 | -12.480 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 87.771 | 89.428 | 87.700 | 80.282 | 53.141 |
| 存貨周轉天數 (天) | 77.658 | 79.425 | 90.395 | 109.623 | 131.575 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
